Reliance Global Group, Inc. (EZRA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on August 5, 2026, covering events occurring on July 30, 2026. Reliance Global Group, Inc. is a Florida corporation with principal executive offices in Lakewood, New Jersey. The filing primarily addresses a strategic transaction involving the sale of a subsidiary.
Key Financial Metrics and Transaction Terms
The filing details a proposed sale of substantially all operating assets of the Company's Altruis Benefit Consulting subsidiary. The filing does not provide current period revenue, profit, cash flow, or debt metrics for the Company as a whole.
- Proposed Transaction Value: $11,000,000 cash purchase price.
- Cash at Closing: Approximately $9,350,000 (subject to working capital adjustments).
- Escrow Amount: Approximately $1,650,000 held for 18 months for indemnification purposes.
- Target Closing Date: On or before September 24, 2026.
Material Changes and Strategic Actions
The Company entered into a non-binding letter of intent (LOI) to sell its Michigan-based health insurance agency and benefits consulting business, Altruis. The Buyer will assume certain specified liabilities of Altruis. This represents a potential material change to the Company's asset base and future revenue streams, contingent upon the execution of definitive agreements.
Guidance, Risks, and Contingencies
The LOI is non-binding regarding principal economic terms, except for exclusivity, confidentiality, and expense allocation. The Company has agreed to an exclusivity period from July 30, 2026, through October 16, 2026, during which it cannot solicit competing proposals.
Key Risks and Contingencies:
- Transaction Uncertainty: There is no assurance that definitive agreements will be executed or that the transaction will close.
- Closing Conditions: The deal is subject to due diligence (including quality-of-earnings review), continuity of carrier appointments, lender lien releases, third-party consents, board approvals, and the Buyer's ability to secure financing.
- Forward-Looking Statements: The filing contains forward-looking statements regarding the use of proceeds and financial flexibility, which are subject to significant risks and uncertainties.
Investor Verification Checklist
- Verify the execution of definitive purchase agreements prior to the target closing date of September 24, 2026.
- Confirm the satisfaction of closing conditions, specifically the continuity of Altruis's material carrier appointments and the release of lender liens.
- Monitor for any material changes to the purchase price or terms in the definitive agreements compared to the LOI.
- Assess the impact of the potential sale on the Company's remaining business operations and capital structure.